Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions

Clinical trial NCT02265341 · COMPLETED

Trial details

NCT number: NCT02265341
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Hepatobiliary Neoplasm

Start date: 2014-12-01
Primary completion: 2018-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.